ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS from May 2001: |
Osteopenia in HIV-infected
patients:
is it the disease or is it the treatment? & Nucleosides (NRTIs)
and Reduced Bone Mineral Density (Osteopenia) Milk Thistle in
HCV: Randomized
controlled trial of silymarin (milk thistle) treatment in patients with
cirrhosis of the liver Reports for NATAP from the Small Study
Suggests HIV Therapy May Reduce HCV Transmission Methadone Promotes
HIV Infection in Cell Culture Studies at The Children's Hospital of Philadelphia
Immune Suppression
(low CD4s) and Cervical Dysplasia in Women: studies suggest relationship Reports for NATAP from
the Sexual Risk of
HCV Transmission Effects of mode of
delivery and infant feeding on the risk of mother-to-child transmission
of hepatitis C virus Amantadine+Interferon/Ribivarin
in Interferon Non-Responders Durability
of Sustained Virologic Response: 3 year follow-up Entecavir:
new Hepatitis B drug in early research Assessment of
Fatigue and Psychologic Disturbances in Patients with Hepatitis C Virus
Infection New Ribivarin
in Research (ICN 17261) More on Amantadine
in Combination with Interferon and Ribivarin Study Finds Aerobic
Exercise Can Lead to Subcutaneous Fat Loss in Periphery (lipoatrophy)
Non-Hodgkins Lymphoma New Perinatal Guidelines ALT Levels
(liver enzymes) Can Be Normal but Liver Disease Can Be Advanced |